Denmark will not include Johnson & Johnson’s vaccine in its Covid immunization program over blood-clot concerns, according to media reports. Authorities in Denmark are being extra cautious and excluding AstraZeneca’s vaccine too.
A contract plant that was producing materials for Johnson & Johnson’s (J&J) CCP virus vaccines failed to meet sanitary standards, according to federal health authorities.
The Johnson & Johnson and AstraZeneca COVID vaccines are under the microscope for their potential to cause blood clots, but scientists warn Pfizer and Moderna vaccines pose similar risks.
Concerns over adverse reactions, blood clots, reports of breakthrough COVID cases in vaccinated people, vaccine contamination and scrutiny over CEO pay have plagued the roll-out of the company’s COVID vaccine.
A vaccination site in Wake County, North Carolina, paused operations on Thursday after 18 adverse reactions to the Johnson & Johnson CCP virus vaccine were reported, officials said.
A mass vaccination site in Colorado was shut down and 600 people with appointments turned away after 11 people experienced reactions, but state officials say side effects were “consistent with what’s expected.”
As media cheered emergency approval of J&J’s COVID vaccine and the company’s plans to team up with Merck on production, there was little mention of safety concerns or the two companies’ criminal track records.
Some U.S. bishops are advising Roman Catholics to avoid the Johnson & Johnson COVID-19 vaccine, saying it is immoral because aborted human tissue is used in its manufacture.
Days after the FDA approved J&J’s COVID vaccine for emergency use, the company announced plans to test the vaccine on newborns, despite the vaccine’s...
